Esben Andreas Carlsen

Esben Andreas Carlsen

Ph.d.-studerende


Udgivelsesår:
  1. 2023
  2. Udgivet

    An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose 64Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms

    Loft, Mathias Hougaard, Ladefoged, C. N., Johnbeck, C. B., Carlsen, Esben Andreas, Oturai, P., Langer, Seppo W., Knigge, Ulrich, Andersen, Flemming Littrup & Kjær, Andreas, 2023, I: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 64, 6, s. 951-959

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  3. Udgivet

    Diagnostic Value of Preoperative uPAR-PET/CT in Regional Lymph Node Staging of Oral and Oropharyngeal Squamous Cell Carcinoma: A Prospective Phase II Trial

    Lawaetz, Mads, Christensen, Anders, Juhl, Karina, Lelkaitis, G., Karnov, K., Carlsen, Esben Andreas, Charabi, Birgitte Wittenborg, Loft, A., Czyzewska, D., von Buchwald, Christian & Kjær, Andreas, 2023, I: Diagnostics. 13, 21, s. 1-12 3303.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  4. 2022
  5. Udgivet

    Activity Dose Reduction in 64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability.

    Loft, M., Carlsen, Esben Andreas, Johnbeck, C. B., Jensen, C. V., Andersen, Flemming Littrup, Langer, Seppo W., Oturai, P., Knigge, Ulrich & Kjær, Andreas, 2022, I: Molecular Imaging and Biology. 24, s. 600–611

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  6. Udgivet

    First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic

    Loft, Mathias Hougaard, Christensen, C., Clausen, Malene Martini, Carlsen, Esben Andreas, Hansen, C. P., Kroman, Niels Thorndahl, Langer, Seppo W., Høgdall, Claus Kim, Madsen, J., Gillings, N., Nielsen, Carsten Haagen, Klausen, Thomas Levin, Holm, S., Loft, A., Berthelsen, A. K. & Kjær, Andreas, 2022, I: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63, 12, s. 1871-1879

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  7. Udgivet

    Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy

    Carlsen, Esben Andreas, Loft, Mathias Hougaard, Loft, A., Berthelsen, A. K., Langer, Seppo W., Knigge, Ulrich & Kjær, Andreas, 2022, I: Journal of Nuclear Medicine. 63, 9, s. 1371-1377

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  8. Udgivet

    Reduction of 64Cu-DOTATATE activity dose for somatostatin receptor PET imaging of patients with neuroendocrine neoplasms

    Loft, Mathias Hougaard, Carlsen, Esben Andreas, Johnbeck, C. B., Jensen, C. V., Andersen, Flemming Littrup, Langer, Seppo W., Otorai, P., Knigge, Ulrich & Kjær, Andreas, 2022, I: Journal of Neuroendocrinology. 34, S1, s. 151-151 1 s.

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

  9. 2021
  10. Udgivet

    Semi-automatic tumor delineation for evaluation of 64Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume

    Carlsen, Esben Andreas, Johnbeck, C. B., Loft, Mathias Hougaard, Pfeifer, A., Oturai, P., Langer, Seppo W., Knigge, Ulrich, Ladefoged, C. N. & Kjær, Andreas, 2021, I: The Journal of Nuclear Medicine. 62, 11, s. 1564-1570

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

ID: 257010409